Wixela Inhub is indicated for the twice daily treatment of asthma in patients age four and older not adequately controlled on long-term asthma medications or whose disease warrants initiation of ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.

Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is changing how certain asthma ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...

Effective April 15, 2025, some patients will need to self-administer asthma medications at home rather than receiving them at a clinic. The affected medications include Fasenra, Tezspire ...

and key management strategies include avoiding triggers and using medication to prevent worsening of symptoms that can land people in the hospital. Asthma Tool is intended to help users better ...

The company blamed for the death of a young Wisconsin man who died from an asthma attack after his medication price rose from ...

Living with asthma and related respiratory issues can be a nightmare, with attacks striking out of nowhere and no ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. The field of ...